A randomized, double-blind, Phase 3 study comparing efficacy and safety of frexalimab (SAR441344) to placebo in adult participants with nonrelapsing secondary progressive multiple sclerosis
Details
Age
Adult
Locations
Brain Imaging Center (BIC) - Scan Read
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Enrique Alvarez
Study ID
Protocol Number: 23-2271
More information available at ClinicalTrials.gov: NCT06141486
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers